| Recent updates on GLP-1 agonists: Current advancements & challenges D Sharma, S Verma, S Vaidya, K Kalia, V Tiwari Biomedicine & Pharmacotherapy 108, 952-962, 2018 | 266 | 2018 |
| Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges V Fernandes, D Sharma, S Vaidya, S PA, Y Guan, K Kalia, V Tiwari Expert opinion on therapeutic targets 22 (2), 131-142, 2018 | 64 | 2018 |
| Attenuation of ongoing neuropathic pain by peripheral acting opioid involves activation of central dopaminergic neurocircuitry S Vaidya, PA Shantanu, V Tiwari Neuroscience Letters 754, 135751, 2021 | 27 | 2021 |
| Tozasertib attenuates neuropathic pain by interfering with aurora kinase and KIF11 mediated nociception A Uniyal, PA Shantanu, S Vaidya, DA Belinskaia, NN Shestakova, ... ACS Chemical Neuroscience 12 (11), 1948-1960, 2021 | 19 | 2021 |
| Kinesins: motor proteins as novel target for the treatment of chronic pain PA Shantanu, D Sharma, M Sharma, S Vaidya, K Sharma, K Kalia, ... Molecular Neurobiology 56 (6), 3854-3864, 2019 | 15 | 2019 |
| Clinical effectiveness of muscarinic receptor-targeted interventions in neuropsychiatric disorders: A systematic review S Vaidya, AA Guerin, LC Walker, AJ Lawrence CNS drugs 36 (11), 1171-1206, 2022 | 14 | 2022 |
| Implications of COVID-19 on Alcoholism: New Battle of the Health Care System S Vaidya Asia Pacific Journal of Public Health 33 (2-3), 318-319, 2021 | 2 | 2021 |
